- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
NGO working for gas victims opposes Bharat Biotech Covaxin trial in Bhopal
"One gas victim has already died within 10 days of getting the trail shot and many continue to have health complaints of serious nature, "Bee alleged.
Bhopal: At least four NGOs working for the survivors of the 1984 Bhopal gas tragedy on Sunday wrote to Prime Minister Narendra Modi demanding that the ongoing clinical trials for Covaxin, an indigenously developed Covid-19 vaccine, be stopped in the Madhya Pradesh capital in view of the "gross violation of laws and guidelines". In the letters addressed to the PM and Union Health Minister...
Bhopal: At least four NGOs working for the survivors of the 1984 Bhopal gas tragedy on Sunday wrote to Prime Minister Narendra Modi demanding that the ongoing clinical trials for Covaxin, an indigenously developed Covid-19 vaccine, be stopped in the Madhya Pradesh capital in view of the "gross violation of laws and guidelines".
In the letters addressed to the PM and Union Health Minister Harsh Vardhan, these NGOs have also sought punishment for the "responsible parties who were negligent in ensuring the safety, well being and the rights of the trial participants".
Ruchika Sharma joined Medical Dialogue as an Desk Editor for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751